HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long Dai Selected Research

CVT 313

11/2021A network pharmacology approach to investigate the anticancer mechanism of cinobufagin against hepatocellular carcinoma via downregulation of EGFR-CDK2 signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Long Dai Research Topics

Disease

2Hepatocellular Carcinoma (Hepatoma)
01/2022 - 11/2021
2Neoplasms (Cancer)
01/2022 - 11/2021
1Liver Neoplasms (Liver Cancer)
01/2022
1Alcoholism (Alcohol Abuse)
11/2020
1Postmenopausal Osteoporosis
06/2013
1Osteoporosis
06/2013

Drug/Important Bio-Agent (IBA)

1Glucose (Dextrose)FDA LinkGeneric
01/2022
1huachansuIBA
01/2022
1Lactic Acid (Lactate)FDA LinkGeneric
01/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2021
1chan su (ChanSu)IBA
11/2021
1CVT 313IBA
11/2021
1Gefitinib (Iressa)FDA Link
11/2021
1Proteoglycans (Proteoglycan)IBA
11/2021
1cinobufaginIBA
11/2021
1puerarinIBA
11/2020
1Investigational DrugsIBA
11/2020
1GalliumIBA
06/2013
1StrontiumIBA
06/2013
1GermaniumIBA
06/2013

Therapy/Procedure

2Therapeutics
11/2021 - 06/2013
1Chinese Traditional Medicine (Traditional Chinese Medicine)
11/2021